Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -2.00 | -2.00 | -12.86 | -20.59 | -30.81 |
EBIT | -2.00 | -2.00 | -12.86 | -20.59 | -30.81 |
Other financial expenses | -1.06 | -1.19 | -1.80 | -6.79 | -65.55 |
Net income from associates (fin.) | - 121.56 | -35.23 | 192.52 | -10.72 | |
Pre-tax profit | - 124.62 | -38.43 | 177.86 | -38.11 | -96.36 |
Net earnings | - 124.62 | -38.43 | 177.86 | -38.11 | -96.36 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Tangible assets total | |||||
Participating interests | 373.48 | 337.25 | 329.77 | ||
Investments total | 373.48 | 337.25 | 329.77 | ||
Long term receivables total | |||||
Inventories total | |||||
Current other receivables | 0.35 | ||||
Short term receivables total | 0.35 | ||||
Other current investments | 12.20 | 317.58 | |||
Cash and bank deposits | 0.04 | 0.04 | 181.82 | 441.86 | 0.39 |
Cash and cash equivalents | 0.04 | 0.04 | 181.82 | 454.06 | 317.97 |
Balance sheet total (assets) | 373.52 | 337.29 | 511.59 | 454.06 | 318.32 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
Shares repurchased | 40.00 | 40.00 | |||
Other reserves | 308.48 | 272.25 | 264.77 | ||
Retained earnings | 34.31 | -55.08 | -86.03 | 316.60 | 238.50 |
Profit of the financial year | - 124.62 | -38.43 | 177.86 | -38.11 | -96.36 |
Shareholders equity total | 343.17 | 303.75 | 481.60 | 443.49 | 307.13 |
Non-current liabilities total | |||||
Current trade creditors | 2.00 | 2.00 | 2.00 | 3.50 | 3.50 |
Current owed to participating | 28.35 | 31.54 | 27.99 | 7.06 | 7.68 |
Current liabilities total | 30.35 | 33.54 | 29.99 | 10.56 | 11.18 |
Balance sheet total (liabilities) | 373.52 | 337.29 | 511.59 | 454.06 | 318.32 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.